Online tools and tumor tissue tests designed to help women with invasive breast cancer understand and assess their treatment options.
Learn more about your treatment options:
This calculator gives the breast cancer survival and other information, projected over time, with and without various adjuvant chemo- and hormonal therapies, presuming the same reduction in death values that were adopted by AdjuvantOnline.
Our articles can help you understand your cancer stage and appropriate options, so you and your doctors can arrive at the best treatment plan
Oncotype DX is a clinically validated laboratory test, ordered by physicians, that predicts the likelihood of breast cancer recurrence in women with newly diagnosed, early stage invasive breast cancer. Oncotype DX also assesses the benefit from certain types of chemotherapy.
MammPrint is a test that uses microarray analysis to assess the activity of 70 genes to predict whether a patient is low or high risk of having the cancer metastasize.
For additional information, please visit Treatment Options.